enGene Holdings Inc.ENGNNASDAQ
Loading
SG&A Expense Growth Recovery in ProgressRecovering
Percentile Rank53
Year-over-Year Change
Year-over-year SG&A expense growth
Percentile
P53
Within normal range
vs 2Y Ago
0.1x
Contraction
Streak
1 qtr
Consecutive growthRecovering
| Period | Value |
|---|---|
| Q4 2025 | 13.88% |
| Q3 2025 | 6.61% |
| Q2 2025 | 15.19% |
| Q1 2025 | -22.04% |
| Q4 2024 | 17.36% |
| Q3 2024 | 7.79% |
| Q2 2024 | 67.50% |
| Q1 2024 | -18.04% |
| Q4 2023 | 161.90% |
| Q3 2023 | 21.28% |
| Q2 2023 | 47.41% |
| Q1 2023 | 80.98% |
| Q4 2022 | -18.75% |
| Q3 2022 | -14.02% |
| Q2 2022 | 0.00% |
| Q4 2021 | 0.00% |